CSAM Health Group AS ("CSAM"), the leading provider of niche eHealth solutions in the Nordics, today announced it has signed a deal to acquire eHealth player Optima Corporation Ltd from Chicago, USA-based R1 RCM.

With the acquisition of Optima Corporation, CSAM Health Group will bring market-leading Optima products, impressive customer base and skilled teams in Auckland, New Zealand, Chicago, US, and Reading, UK, into the CSAM family.

Novartis and Hewlett Packard Enterprise (HPE)announced a collaboration that aims to accelerate the use of data and digital technologies within Novartis efforts to reimagine global health and improve access to healthcare and medicines.

The UK Department of Health and Social Care announced that Qure.ai has been selected as one of the winners of the Artificial Intelligence in Health and Care Award, sponsored by the UK government. Qure.ai is a 5-year-old Sequoia-funded company builds Artificial Intelligence (AI) powered solutions to facilitate identification and treatment of stroke and head injuries.

The U.S. Food and Drug Administration authorized marketing of a device to help diagnose autism spectrum disorder (ASD). The Cognoa ASD Diagnosis Aid is a machine learning-based software intended to help health care providers diagnose ASD in children 18 months through 5 years of age who exhibit potential symptoms of the disorder.

Black Country Pathology Services has worked with CliniSys to create the ICE Portal, a web-based application that makes it easy for care homes, or other community care settings, to be able to order lab based COVID-19 tests and see the results.

Highland Marketing's advisory board welcomed Jane Brightman, social care lead at Institute of Health and Social Care Management, to discuss the sector and its technology needs. A lot of hope is being pinned on integrated care systems, but when it comes to joining up health and care systems and putting the underpinning IT in place, cultural, structural and funding challenges remain.

Cool Clinical announced the release of the publication on the first Artificial Intelligence system for predicting outcomes of cancer treatment, using data from clinical trials. This is a breakthrough for AI approaches to cancer treatment, because clinical trial data are widely available; this research therefore shows the way for precision medicine systems for cancer which are very feasible to develop.